Scenario.press - libera espressione Scenario.press - libera espressione
Rezultatele cautarii
Vedeti tot
  • Conecteaza-te
    Conecteaza-te
    Inscrie-te
    Căutare
    Night Mode

Căutare

Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni

  • News Feed
  • EXPLORE
  • Pagini
  • Grupuri
  • Events
  • Reels
  • Blogs
  • Anunturi
  • Funding
  • Offers
  • Jobs
  • Courses
  • Movies
  • Developers
  • Postari
  • Blogs
  • Utilizatori
  • Pagini
  • Grupuri
  • Events
  • akshayg a adăugat un sunet Health
    2025-12-19 11:00:09 -
    Biosimilar Contract Manufacturing Market Growth, Trends, Company Profiles, Market Share Analysis By FMI
    The biosimilar contract manufacturing market is on the cusp of transformative growth, driven by the escalating demand for cost-effective biopharmaceuticals and the strategic shift toward outsourcing among global pharma giants. According to the latest comprehensive analysis, the market, valued at USD 8.9 billion in 2025, is forecasted to expand at a robust compound annual growth rate...
    0 Commentarii 0 Distribuiri 146 Views
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • jamessmithjimmy12 a adăugat un sunet Health
    2025-05-13 04:44:09 -
    Biosimilar Market Size, Share, Trends, Business Strategies and Opportunities with Key Players Analysis 2033
    IMARC Group, a leading market research company, has recently releases report titled “Biosimilar Market Size, Share, Trends and Forecast by Molecule, Indication, Manufacturing Type, and Region, 2025-2033”. The study provides a detailed analysis of the industry, including the global biosimilar market trends, share, size and growth forecast. The report also includes competitor and...
    0 Commentarii 0 Distribuiri 3K Views
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • akshayg a adăugat un sunet Networking
    2025-09-01 10:22:09 -
    Pegfilgrastim Biosimilar Market, Trends, Covid-19 Impact Analysis, Size And Growth Estimation by Fact MR
    As per Fact.MR’s latest industry analysis, the global pegfilgrastim biosimilar market stands at US$ 1.41 billion in 2023. Global demand for pegfilgrastim biosimilars is projected to reach a market valuation of US$ 3.66 billion by 2033-end, increasing at a CAGR of 10% over the next ten years.This substantial growth is driven by the rising incidence of cancer worldwide, increasing adoption...
    0 Commentarii 0 Distribuiri 1K Views
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • jamessmithjimmy12 a adăugat un sunet Alte
    2025-09-23 10:22:29 -
    Biosimilar Market is Projected to Reach USD 185.1 Billion by 2033 | At CAGR 24.1%
    Overview of the Biosimilar Market: The biosimilar market refers to biologic medical products that are highly similar to already approved reference biologics in terms of safety, purity, and efficacy. Biosimilars are playing a crucial role in expanding access to advanced therapies while reducing healthcare costs. They are widely used in treating chronic diseases such as cancer, autoimmune...
    0 Commentarii 0 Distribuiri 1K Views
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • riyajattar a adăugat un sunet Alte
    2025-09-19 06:44:30 -
    Key Market Drivers for Biosimilar Monoclonal Antibodies Market: Forecast to 2033
    Biosimilar Monoclonal Antibodies Market Overview Imagine a world where cutting-edge tech transforms industries, boosts efficiency, and opens doors to endless innovation. That's the promise of the market, and according to Straits Research, it's on a rocket ship trajectory with a robust The global biosimilar monoclonal antibodies market size was valued at USD 14.92 Billion in...
    0 Commentarii 0 Distribuiri 1K Views
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
© 2025 Scenario.press - libera espressione Romaian
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About us Terms & Conditions Confidențialitate Business Model Donations Contacteaza-ne Director